Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact® Radiation Delivery System and VitalHold™ Technology

Core Insights - Accuray Incorporated and Halifax Health have introduced the Radixact® System with VitalHold™ technology, marking the first use of this advanced patient positioning system for cancer treatment in the U.S. [1][5] - The VitalHold feature enhances precision in radiation delivery by providing effective patient positioning and monitoring throughout treatment [1][3][4] - The Radixact System is designed to accommodate a growing number of cancer cases, with an estimated 35% increase in new cancer cases in the U.S. projected between 2022 and 2040 [3] Company Overview - Accuray is focused on expanding the capabilities of radiation therapy to improve patient outcomes, emphasizing continuous innovation in oncology and neuro-radiosurgery [8] - Halifax Health is recognized for its comprehensive healthcare services, including a cancer treatment center that utilizes advanced technologies like the Radixact System [7] Technology and Features - The Radixact System is augmented with Accuray's ClearRT® helical CT imaging and Synchrony® real-time adaptive delivery technologies, facilitating faster and safer treatment for various cancer types [2] - VitalHold incorporates a surface-guided radiotherapy (SGRT) solution, allowing for tattoo-free positioning and enhancing patient comfort while ensuring accurate treatment delivery [4][5] - The system supports deep inspiration breath hold (DIBH) treatments, which help minimize radiation exposure to surrounding organs, thereby reducing potential complications [4]